Warfarin FDA Link Generic

An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.

Also Known As:

Coumadin; Warfarin Sodium; 4- Hydroxy- 3- (3- oxo- 1- phenylbutyl)- 2H- 1- benzopyran- 2- one; Aldocumar; Apo-Warfarin; Coumadine; Gen-Warfarin; Marevan; Tedicumar; Warfant; Warfarin Potassium; Potassium, Warfarin; Sodium, Warfarin; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-

Pharmalogical Action Categories:

Anticoagulants
Rodenticides

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Pyrans: 131
    - Benzopyrans: 198
      - Coumarins: 856
        4-Hydroxycoumarins: 2
        Warfarin: 13944
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 198
      - Coumarins: 856
        4-Hydroxycoumarins: 2
        Warfarin: 13944

Jon Blazawski Selected Research

Jon Blazawski Research Topics

Disease

Drug/Important Bio-Agent (IBA)